Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease
Katherine Lietz, Ranjit John, Elizabeth Burke, Michael Schuster, Tyson B. Rogers, Nicole Suciu-Foca, Donna Mancini, Silviu Itescu
Dive into the research topics of 'Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease'. Together they form a unique fingerprint.